ADVB Financials

Income Statement
MetricQ1 2027Q4 2026Q3 2026Q2 2026Q1 2026
Revenue
0
-100.0%
127.6K
0
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
-100.0%
127.6K
0
0
0
Operating Expenses
973.9K
-80.7%
5.0M
+871.4%
519.8K
+31.1%
396.6K
+169.5%
147.2K
R&D
0
+100.0%
-665140
-373.5%
243.2K
+30.5%
186.3K
0
SG&A
973.9K
-83.0%
5.7M
+1966.1%
276.6K
+31.5%
210.3K
+42.9%
147.2K
Operating Income
-973931
+80.2%
-4922189
-846.9%
-519836
-31.1%
-396642
-169.5%
-147155
EBITDA
-973931
+80.4%
-4966650
-872.9%
-510510
-24.7%
-409499
-178.3%
-147155
Net Income
-989054
-242.3%
695.0K
+242.1%
-488942
-107.1%
6.9M
+1872.5%
-386901
EPS (Basic)
$-0.60
-236.4%
$0.44
+215.8%
$-0.38
-106.1%
$6.20
+1822.2%
$-0.36
EPS (Diluted)
$-0.60
-236.4%
$0.44
+215.8%
$-0.38
-106.1%
$6.20
+1822.2%
$-0.36
Shares (Diluted)
1.7M
+5.8%
1.6M
+21.6%
1.3M
+18.8%
1.1M
+0.0%
1.1M
Advanced Biomed (ADVB) — Financials